跳至主要内容
临床试验/NCT03981510
NCT03981510Unknown不适用

Comparison of Gastrointestinal Motility in Healthy Children and Children With Constipation

University of Aarhus1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2019年6月13日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
80
试验地点
1
主要终点
The investigation is without discomfort and adverse events.

研究概览

简要总结

To gain a better understanding of the underlying dysmotility in constipation in children, we will use a novel minimal invasive method called 3D Transit. We will examine four groups of children aged 7 to 17 years: healthy children, chronically constipated children (ROM IV criteria), children with neurofibromatosis type 1 and finally children receiving chemotherapy (vincristin) for acute lymphoblastic leukemia.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
7 Years 至 17 Years(Child)
性别
All
接受健康志愿者
是

入选标准

  • •applicable to all participants:
  • •Children between 7-17 years of age where permission is granted for the participation by habitable parents with custody of the child. In case of joint custody, permission must be obtained from both parents.
  • •Inclusion criteria applicable only to healthy participants:
  • •Gastrointestinal healthy children without chronic constipation
  • •Inclusion criteria applicable only to constipated participants:
  • •Chronic constipation defined by Rom IV criteria, which is a diagnostic score for chronic constipation
  • •Inclusion criteria applicable only to children in vincristine treatment:
  • •Children with cancer in treatment with vincristine
  • •Inclusion criteria applicable only to patients with NF1:
  • •Diagnosis of NF1 with gastrointestinal symptoms

排除标准

  • •Children with parents who are unable to understand the given particpant's information
  • •Children with known dysregulated metabolic disease
  • •Previously major intra-abdominal surgery
  • •CNS surgery
  • •Other treatment-requiring gastrointestinal disorder
  • •Systemic steroid treatment within the last week
  • •Children with difficulty swallowing
  • •Children with known gastrointestinal obstruction or perforation
  • •Acute infections
  • •Diagnosed malabsorption including bile acid malabsorption
  • •Menarche in girls

研究组 & 干预措施

Children being investigated with 3D-transit

Experimental

4 groups of each 20 children will be investigated with respectively one or two capsules:

  • Healthy children (1)
  • Children with chronic constipation (2)
  • Children with neurofibromatosis type 1 (2)
  • Children with cancer receiving treatment with Vincristine (1)

干预措施: 3D-Transit (Diagnostic Test)

结局指标

主要结局

The investigation is without discomfort and adverse events.

时间窗: 3 days

Children in Vincristine treatment has a longer transit time through the colon and fewer fast bowel movements than healthy children.

时间窗: 3 days

Children with NF1 and gastrointestinal symptoms has a longer transit time through the colon and fewer fast bowel movements than healthy children.

时间窗: 3 days

Children with chronic constipation has a longer transit time through the colon and fewer fast bowel movements than healthy children.

时间窗: 3 days

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验